In cancer science, many "discoveries" don’t reason up

NEW YORK (Reuters) A former researcher during Amgen Inc has found that many simple studies on cancer a high suit of them from university labs are unreliable, with grave consequences for producing new medicines in a future.
During a decade as conduct of tellurian cancer research during Amgen, C. Glenn Begley identified 53 landmark publications papers in tip journals, from creditable labs for his organisation to reproduce. Begley sought to double-check a explanation before perplexing to build on them for drug development.
Result: 47 of a 53 could not be replicated. He described his explanation in a explanation square published on Wednesday in a biography Nature.
It was shocking, pronounced Begley, now comparison clamp boss of secretly reason biotechnology association TetraLogic, that develops cancer drugs. These are a studies a curative attention relies on to brand new targets for drug development. But if youre going to place a $1 million...